Canada Markets close in 3 hrs 17 mins

Second Sight Medical Products, Inc. (EYES)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.5384+0.0684 (+4.65%)
As of 12:35PM EDT. Market open.

Second Sight Medical Products, Inc.

13170 Telfair Avenue
Sylmar, CA 91342
United States
818 833 5000

IndustryMedical Devices
Full Time Employees15

Key Executives

NameTitlePayExercisedYear Born
Mr. Scott DunbarActing Chief Exec. Officer255.3kN/A1958
Mr. Edward Jonathon SedoActing Chief Accounting Officer & Principal Financial Officer151.08kN/A1956
Mr. Edward David RandolphVP of Operations167.5kN/A1958
Dr. Jessy Dana Dorn Ph.D.VP of Clinical & Scientific Affairs233.99kN/A1976
Gunnar BjorgFounderN/AN/AN/A
Ms. Lisa M. WilsonFounder & Pres of In-Site Communications and Investor Relations for Second SightN/AN/A1965
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.

Corporate Governance

Second Sight Medical Products, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.